Nutriband Inc. (NTRB)
Stock Price:
$6.02 USD
-1.23 (-16.97%)
Updated Oct 26, 2020 12:42 PM EDT - Market open
Key Info
| Market Cap |
36.88M |
| Revenue (ttm) |
305,958 |
| Net Income (ttm) |
-2.34M |
| Shares Out |
6.13M |
| EPS (ttm) |
-0.43 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 26, 2020 |
| Last Price |
$6.02 |
| Previous Close |
$7.25 |
| Change ($) |
-1.23 |
| Change (%) |
-16.97% |
| Day's Open |
6.95 |
| Day's Range |
6.02 - 9.00 |
| Day's Volume |
605 |
| 52-Week Range |
6.05 - 29.9 |
More Stats
| Market Cap |
36.88M |
| Enterprise Value |
36.98M |
| Earnings Date (est) |
n/a |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
6.13M |
| Float |
3.03M |
| EPS (basic) |
-0.43 |
| EPS (diluted) |
-0.43 |
| FCF / Share |
-0.13 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
n/a |
| Short Ratio |
n/a |
| Short % of Float |
n/a |
| Beta |
-0.64 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
120.54 |
| PB Ratio |
34.25 |
| Revenue |
305,958 |
| Operating Income |
-1.32M |
| Net Income |
-2.34M |
| Free Cash Flow |
-697,554 |
| Net Cash |
-100,189 |
| Net Cash / Share |
-0.02 |
| Gross Margin |
-58.33% |
| Operating Margin |
-431.42% |
| Profit Margin |
-763.40% |
| FCF Margin |
-227.99% |
| ROA |
-36.24% |
| ROE |
-159.45% |
| ROIC |
231.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (0)
| Buy |
0 |
| Overweight |
0 |
| Hold |
0 |
| Underweight |
0 |
| Sell |
0 |
Low
24.0
Current: $6.02
High
24.0
Target: 24.00
*Average 12-month price target from 1 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 |
|---|
| Revenue | 0.37 | 0.25 | - | - |
| Revenue Growth | 51.11% | - | - | - |
| Gross Profit | -0.18 | -0.04 | - | - |
| Operating Income | -1.97 | -3.33 | -2.67 | -0.15 |
| Net Income | -2.72 | -3.33 | -2.67 | -0.15 |
| Shares Outstanding | 5.42 | 5.35 | 4.80 | 5.30 |
| Earnings Per Share | -0.50 | -0.62 | -0.56 | -0.04 |
| Operating Cash Flow | -0.89 | -1.11 | -0.09 | -0.15 |
| Capital Expenditures | - | - | - | - |
| Free Cash Flow | -0.89 | -1.11 | -0.09 | -0.15 |
| Cash & Equivalents | 0.01 | 0.47 | - | 0.03 |
| Total Debt | 0.32 | 0.04 | 0.02 | - |
| Net Cash / Debt | -0.31 | 0.43 | -0.02 | 0.03 |
| Assets | 2.20 | 2.81 | 0.16 | 0.04 |
| Liabilities | 2.02 | 0.40 | 0.04 | 0.01 |
| Book Value | 0.18 | 2.40 | 0.12 | 0.02 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Nutriband Inc. |
| Country |
United States |
| Employees |
3 |
| CEO |
Gareth R. Sheridan |
Stock Information
| Ticker Symbol |
NTRB |
| Stock Exchange |
US OTC |
| Sector |
Healthcare |
| Industry |
Biotechnology |
| Unique Identifier |
OTCMKTS: NTRB |
Description
Nutriband develops a portfolio of transdermal pharmaceutical products. The company's lead product in development is abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain. Its product line consists of an energy patch line; a weight management patch line; a multivitamin patch line; a children's multivitamin patch line; an amino acid patch line; an anti-wrinkle patch line; an insect repellant patch line; a detox patch line; a PMS patch line; a sleep patch line; and a nausea and motion sickness patch line. The company was incorporated in 2016 and is headquartered in Orlando, Florida.